| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | €7.10B | -8.74 | 25.83% | 2.08% | -8.61% | -80.32% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | €852.79M | -8.72 | 6.02% | 3.94% | -4.60% | -75.90% | |
53 Neutral | €76.08M | 4.98 | 9.39% | 2.13% | -5.53% | ― | |
45 Neutral | €34.09M | -9.31 | -25.78% | ― | -54.49% | -11.52% | |
43 Neutral | €33.98M | -0.65 | ― | ― | -20.60% | -74.22% |